Vaccine potential of HLA‐A2 epitopes from Leishmania Cysteine Protease Type III (CPC) - Dikhit, M. R.; Amit, A.; Singh, A. K.; Kumar, A.; Mansuri, R.; Sinha, S.; Topno, R. K.; Mishra, R.; Das, V. N. R.; Pandey, K.; Sahoo, G. C.; Ali, V.; et al. (Parasite immunology, 2017)
Keywords: Adolescent; Adult; CD3 antigen; CD8 antigen; CD8+ T cell; CD8-Positive T-Lymphocytes - immunology; Cell culture; Cell Proliferation; Cysteine; Cysteine Proteases - chemistry; Cysteine Proteases - immunology; Cysteine proteinase; epitope prediction; Epitopes; Epitopes, T-Lymphocyte - chemistry; Epitopes, T-Lymphocyte - immunology; Female; Histocompatibility antigen HLA; HLA-A2 Antigen - chemistry; HLA-A2 Antigen - immunology; Humans; IFN‐γ; Immune response (cell-mediated); Immunogenicity, Vaccine; Interleukin 10; Interleukin-10 - metabolism; Leishmania; Leishmania - enzymology; Leishmania - immunology; Leishmaniasis Vaccines - immunology; Leishmaniasis, Visceral - drug therapy; Leishmaniasis, Visceral - immunology; Leishmaniasis, Visceral - parasitology; Leukocytes (mononuclear); Leukocytes, Mononuclear - immunology; Lymphocytes T; Major histocompatibility complex; Male; Models, Molecular; Parasitic diseases; Peptides; Peptides - chemical synthesis; Peptides - chemistry; Peptides - immunology; Peripheral blood mononuclear cells; Synthetic peptides; T cell receptors; Vaccines; Visceral leishmaniasis; Young Adult; γ-Interferon; epitope prediction; IFN-γ; CD8+ T cell; visceral leishmaniasis; Leishmania